Altered 13C glucose metabolism in the cortico-striato-thalamo- cortical loop in the MK-801 rat model of schizophrenia

Journal of Cerebral Blood Flow and Metabolism

Volumn 31, Issue 3, 2011, Pages 976-985

  Eyjolfsson, Elvar M ^a,b   Nilsen, Linn Hege ^a   Kondziella, Daniel ^c   Brenner, Eiliv ^a,b   Håberg, Asta ^a   Sonnewald, Ursula ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c Rigshospitalet   (Denmark)

Author keywords

13C NMRS; dopamine; GABA; glutamate; lactate

Indexed keywords

ALANINE; AMINOBUTYRIC ACID DERIVATIVE; ASPARTIC ACID; DIZOCILPINE; DOPAMINE; GABAERGIC RECEPTOR AFFECTING AGENT; GLUCOSE; GLUTAMINE; LACTIC ACID; MALIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER; SEROTONIN; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; AMINO ACID RECEPTOR BLOCKING AGENT; CARBON; DIZOCILPINE MALEATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; CORPUS STRIATUM; FRONTAL CORTEX; GLUCOSE METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; LABELING INDEX; MASS FRAGMENTOGRAPHY; MITOCHONDRIAL MEMBRANE; MONOAMINERGIC NERVE; NONHUMAN; NUCLEUS ACCUMBENS; PARIETAL CORTEX; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; SCHIZOPHRENIA; TEMPORAL CORTEX; THALAMUS; ANIMAL; BRAIN CORTEX; CHEMICALLY INDUCED DISORDER; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SPRAGUE DAWLEY RAT;

ANIMALS; CARBON ISOTOPES; CEREBRAL CORTEX; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORPUS STRIATUM; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GLUCOSE; INJECTIONS, INTRAPERITONEAL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEUROTRANSMITTER AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA; THALAMUS;

EID: 79952185414     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/jcbfm.2010.193     Document Type: Article

References (41)

1. Baslow MH, Guilfoyle DN (2006) Functions of N-acetylaspar-tate and N-acetylaspartyl-glutamate in brain-Evidence of a role in maintenance of higher brain integrative activities of information processing and cognition. Adv Exp Med Biol 576:95-112
2. Beasley CL, Dwork AJ, Rosoklija G, Mann JJ, Mancevski B, Jakovski Z, Davceva N, Tait AR, Straus SK, Honer WG (2009) Metabolic abnormalities in fronto-striatal-thala-mic white matter tracts in schizophrenia. Schizophr Res 109:159-66
3. Bertolino A, Nawroz S, Mattay VS, Barnett AS, Duyn JH, Moonen CT, Frank JA, Tedeschi G, Weinberger DR (1996) Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am J Psychiatry 153:1554-63 (Pubitemid 26406165)
4. Brenner E, Kondziella D, Haberg A, Sonnewald U (2005) Impaired glutamine metabolism in NMDA receptor hypofunction induced by MK801. J Neurochem 94:1594-603 (Pubitemid 41324641)
5. Bustillo JR, Rowland LM, Mullins P, Jung R, Chen H, Qualls C, Hammond R, Brooks WM, Lauriello J (2009) 1H-MRS at 4 Tesla in minimally treated early schizophrenia. Mol Psychiatry 15:629-36
6. Carlsson ML, Carlsson A, Nilsson M (2004) Schizophrenia: from dopamine to glutamate and back. Curr Med Chem 11:267-77 (Pubitemid 38240207)
7. Cesar M, Hamprecht B (1995) Immunocytochemical examination of neural rat and mouse primary cultures using monoclonal antibodies raised against pyruvate carboxy-lase. J Neurochem 64:2312-8
8. Choi IY, Gruetter R (2004) Dynamic or inert metabolism? Turnover of N-acetyl aspartate and glutathione from D-[1-13C]glucose in the rat brain in vivo. J Neurochem 91:778-87 (Pubitemid 39507354)
9. Del Arco A, Mora F (2008) Prefrontal cortex-nucleus accumbens interaction: in vivo modulation by dopa-mine and glutamate in the prefrontal cortex. Pharmacol Biochem Behav 90:226-35
10. Duncan CE, Webster MJ, Rothmond DA, Bahn S, Elashoff M, Shannon Weickert C (2010) Prefrontal GABA(A) receptor alpha-subunit expression in normal postnatal human development and schizophrenia. J Psychiatr Res 44:673-81
11. Eyjolfsson EM, Brenner E, Kondziella D, Sonnewald U (2006) Repeated injection of MK801: an animal model of schizophrenia? Neurochem Int 48:541-6
12. Hassel B, Sonnewald U, Fonnum F (1995) Glial-neuronal interactions as studied by cerebral metabolism of [2-13C]acetate and [1-13C]glucose: an ex vivo 13C NMR spectroscopic study. J Neurochem 64:2773-82
13. Holmes E, Tsang TM, Huang JT, Leweke FM, Koethe D, Gerth CW, Nolden BM, Gross S, Schreiber D, Nicholson JK, Bahn S (2006) Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia. PLoS Med 3:e327
14. Howes OD, Kapur S (2009) The dopamine hypothesis of schizophrenia: version III-the final common pathway. Schizophr Bull 35:549-62
15. Jentsch JD, Roth RH (1999) The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsy-chopharmacol 20:201-25 (Pubitemid 29067401)
16. Kegeles LS, Abi-Dargham A, Zea-Ponce Y, Rodenhiser-Hill J, Mann JJ, Van Heertum RL, Cooper TB, Carlsson A, Laruelle M (2000) Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia. Biol Psychiatry 48:627-40
17. Keselman HJ, Cribbie R, Holland B (2002) Controlling the rate of Type I error over a large set of statistical tests. Br J Math Stat Psychol 55:27-39
18. Kiss T, Hoffmann WE, Hajos M (2010) Delta oscillation and short-term plasticity in the rat medial prefrontal cortex: modelling NMDA hypofunction of schizophrenia. Int J Neuropsychopharmacol 25:1-14
19. Kondziella D, Brenner E, Eyjolfsson EM, Markinhuhta KR, Carlsson ML, Sonnewald U (2006) Glial-neuronal interactions are impaired in the schizophrenia model of repeated MK801 exposure. Neuropsychopharmacol 31:1880-7
20. Kondziella D, Brenner E, Eyjolfsson EM, Sonnewald U (2007) How do glial-neuronal interactions fit into current neurotransmitter hypotheses of schizophrenia? Neurochem Int 50:291-301 (Pubitemid 46097169)
21. Kurumaji A, McCulloch J (1989) Effects of MK-801 upon local cerebral glucose utilisation in conscious rats and in rats anaesthetised with halothane. J Cereb Blood Flow Metab 9:786-94 (Pubitemid 20006898)
22. Lahti AC, Koffel B, LaPorte D, Tamminga CA (1995) Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacol 13:9-19
23. Laruelle M, Kegeles LS, Abi-Dargham A (2003) Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment. Ann N YAcad Sci 1003:138-58 (Pubitemid 38083052)
24. Loscher W, Annies R, Honack D (1991) The N-methyl-D-aspartate receptor antagonist Mk-801 induces increases in dopamine and serotonin metabolism in several brain-regions of rats. Neurosci Lett 128:191-4
25. Loubinoux I, Meric P, Borredon J, Correze JL, Gillet B, Beloeil JC, Tiffon B, Mispelter J, Lhoste JM, Jacques S (1994) Cerebral metabolic changes induced by MK-801: a 1D (phosphorus and proton) and 2D (proton) in vivo NMR spectroscopy study. Brain Res 643:115-24 (Pubitemid 24115084)
26. Lutkenhoff ES, van Erp TG, Thomas MA, Therman S, Manninen M, Huttunen MO, Kaprio J, Lonnqvist J, O'Neill J, Cannon TD (2010) Proton MRS in twin pairs discordant for schizophrenia. Mol Psychiatry 15:308-18
27. Martins-de-Souza D, Gattaz WF, Schmitt A, Novello JC, Marangoni S, Turck CW, Dias-Neto E (2009) Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation. BMC Psychiatry 9:17
28. Olney JW, Farber NB (1995) NMDA antagonists as neurotherapeutic drugs, psychotogens, neurotoxins, and research tools for studying schizophrenia. Neuro-psychopharmacol 13:335-45 (Pubitemid 26007689)
29. Rujescu D, Bender A, Keck M, Hartmann AM, Ohl F, Raeder H, Giegling I, Genius J, McCarley RW, Moller HJ, Grunze H (2006) A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunc-tion: molecular, cellular, functional and Behavioral abnormalities. Biol Psychiatry 59:721-9
30. Rung JP, Carlsson A, Markinhuhta KR, Carlsson ML (2005) (+)-MK-801 induced social withdrawal in rats; a model for negative symptoms of schizophrenia. Prog Neuro-psychopharmacol Biol Psychiatry 29:827-32 (Pubitemid 40897800)
31. Schmitt A, Wilczek K, Blennow K, Maras A, Jatzko A, Petroianu G, Braus DF, Gattaz WF (2004) Altered thalamic membrane phospholipids in schizophrenia: a postmortem study. Biol Psychiatry 56:41-5 (Pubitemid 38813404)
32. Schroeder J, Buchsbaum MS, Siegel BV, Geider FJ, Haier RJ, Lohr J, Wu J, Potkin SG (1994) Patterns of cortical activity in schizophrenia. Psychol Med 24:947-55
33. Steen RG, Hamer RM, Lieberman JA (2005) Measurement of brain metabolites by H-1 magnetic resonance spectro-scopy in patients with review and meta-analysis. Neuropsychopharmacol 30:1949-62 (Pubitemid 43093497)
34. Tanaka Y, Obata T, Sassa T, Yoshitome E, Asai Y, Ikehira H, Suhara T, Okubo Y, Nishikawa T (2006) Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction. Psychiatry Clin Neurosci 60:365-72 (Pubitemid 43736403)
35. Theberge J, Al-Semaan Y, Williamson PC, Menon RS, Neufeld RW, Rajakumar N, Schaefer B, Densmore M, Drost DJ (2003) Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS. Am J Psychiatry 160:2231-3 (Pubitemid 39619619)
36. Uhlhaas PJ, Singer W (2010) Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci 11:100-13
37. Vezzani A, Serafini R, Stasi MA, Caccia S, Conti I, Tridico RV, Samanin R (1989) Kinetics of MK-801 and its effect on quinolinic acid-induced seizures and neurotoxicity in rats. J Pharmacol Exp Ther 249:278-83 (Pubitemid 19115820)
38. Vijayraghavan S, Wang M, Birnbaum SG, Williams GV, Arnsten AF (2007) Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nat Neurosci 10:376-84
39. Wong EH, Knight AR, Woodruff GN (1988) [3H]MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes. J Neurochem 50:274-81 (Pubitemid 18023510)
40. Waagepetersen HS, Sonnewald U, Schousboe A (2003) Compartmentation of glutamine, glutamate, and GABA metabolism in neurons and astrocytes: functional implications. Neuroscientist 9:398-403 (Pubitemid 37204343)
41. Yoon JH, Maddock RJ, Rokem A, Silver MA, Minzenberg MJ, Ragland JD, Carter CS (2010) GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression. J Neu-rosci 30:3777-81